Dr. Shaw has had substantial
experience in the pharmaceutical industry and has held
positions in large pharma, mid-sized and start-up companies.
Prior to joining TechTIPS, Dr. Shaw held the position
of Director of Business Development for Attenuon, LLC,
a pharmaceutical start-up located in Sorrento Valley
focusing on discovery and development of new antiangiogenic
agents for oncology. Prior to that, she was the Director
of Business Development at IDEC Pharmaceuticals, where
she was responsible for the creation and implementation
of a new, in-house contract manufacturing business,
a promotional marketing campaign, and developing potential
out-sourcing clients. In large pharma, Dr. Shaw spent
15 years at Abbott Laboratories, a $3 billion global
diversified health care company. At Abbott, she held
the position of Director, Technology Assessment, Corporate
Licensing and Strategic Planning, and was primarily
responsible for the assessment, acquisition, and licensing
of pharmaceutical and health care technology opportunities.
She was an active participant in Technology Transfer
Conferences and also was on the board of TTC. Dr. Shaw
also held positions in the Pharmaceutical Products Division
including Research Information Scientist, Operations
Manager for the Thrombolytic Venture, and Senior Project
Manager, Research Management and Development where she
was responsible for the planning, prioritizing and managing
the development of new pharmaceutical products for world
wide marketing. Some of the ethical pharmaceutical products
that Dr. Shaw had responsibility for include Hytrin®,
Cefmenoxime, Abbokinase®, Depakote®, Calcijex®,
Zemplar®, and Lupron®.
Dr. Shaw holds a M.S. and Ph.D. in Microbiology/Immunology
from the University of Illinois College of Medicine,
was a postdoctoral student at Argonne National Laboratory,
Division of Biological and Medical Research, and holds
a degree from Blackstone School of Law.
|
